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Abstract—The results of the study of effects of molar ratios in the crystallochemical structure of biomimetic
hydroxyapatite (BMHAP) on the physicochemical characteristics of the product are presented. With an
increase in molar ratio in the range 1.50–1.67, there is an increase in the unit cell parameters a and c, while
the average crystallite size increases from 7.52 to 70.30 nm. Particles of all samples in aqueous suspensions
(pH 7) are negatively charged. The trend of the zeta potential of the synthesized powders in the range of inves-
tigated molar ratios is elucidated. The bioactivity of the samples is evaluated. All BMHAP samples have a
higher bioresorbability as compared to unmodified stoichiometric hydroxyapatite, correlating well with the
molar ratio in the structure of the products
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INTRODUCTION
The development of new synthetic biomaterials
intended for the restoration of bone defects is one of the
topical areas of medical materials science [1–4]. Mate-
rials based on hydroxyapatite ([Са10(PO4)6(ОН)2],
HAP) have been successfully used as implants in
reconstructive surgery, orthopedics, and dentistry for
several years, for they are chemical analogues of
human and animal bone tissue bioapatite [5–8]. How-
ever, ceramic HAP-based implants have unsatisfactory
bioresorbability and poorly induce the formation of new
bone tissue, which is a significant drawback [9, 10].
A promising approach to this problem can be the
development of biomimetic HAP by chemically mod-
ifying it with biocompatible anions in order to pur-
posefully regulate the bioactivity and osteoinduction
of the materials.
According to related literature [11–13], biogenic
apatite is nanostructured calcium-deficient hydroxy-
apatite with appropriate cationic (Na+, Mg2+, K+,
Zn2+, and Sr2+) and anionic (F–, Cl–, , and so
on) substitutions. The presence of these anions in the
HAP structure has a significant effect on a living
organism and stimulates the regeneration of full-
fledged bone tissue.
Silicate and carbonate ions are most important of
the ionic substitutions currently used in the synthesis
of HAP [14–20]. Silicate ions  are of particular
interest in this regard due to their decisive role in bone
tissue restoration, and the incorporation of carbonate
ions into the HAP structure improves resorption and
increases the osteointegration rate.
It was also reported [21, 22] that the addition of
citrate ions (Cit3–) into the reaction medium during
HAP synthesis changes the structural and morpholog-
ical characteristics of the product materials. Citrate
ions participating in biological cycles play an import-
ant role in bone tissue resorption and bioapatite for-
mation, for example, during the nanoscale stabiliza-
tion of HAP crystallites in bone [23–26].
Thus, in terms of chemical composition, bioapatite
is a nanostructured calcium-deficient hydroxyapatite
containing silicate and carbonate ions. We have
already performed a series of studies into the synthesis
of biomimetic calcium-deficient hydroxyapatite
(BMHAP) doped with silicate and carbonate ions in
the presence of citrate ions [22, 27].
Here, we present the results of our study into the
effects of molar ratios  in
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EXPERIMENTAL
The initial reagents used were Ca(NO3)2·4H2O
(pure for analysis grade), (NH4)2HPO4 (pure for anal-
ysis grade), (C2H5O)4Si (TEOS, specialty grade),
(NH4)2CO3 (pure for analysis grade) and NH4OH
(analytical reagent grade). The source of citrate ions
was a citric acid solution prepared beforehand.
BMHAP samples were synthesized by chemical pre-
cipitation from aqueous solution at 22 ± 2°С and
рН 10 ± 0.5 by a known procedure [27]. Citrate ions
Cit3– were added in an amount of 0.46 wt % for regu-
lating nucleation and HAP crystal growth. The
BMHAP precipitation reaction proceeded according
to the equation
where d is the deviation of the molar content of Ca2+
in the HAP crystal structure from the stoichiometric
value; d = 1, 0.7, or 0.4; х is the degree of substitution
of phosphate ions by carbonate ions; and y is the
degree of substitution of phosphate ions by silicate
ions.
The thus-prepared suspension was allowed to stand
for 24 h at room temperature to complete phase for-
mation, then the solid was filtered from the mother
solution, thoroughly washed with distilled water, and
dried to constant weight at 110 ± 5°C.
The subjects chosen to be characterized further
were BMHAP samples where the molar ratios were
 = 1.50, 1.55, and 1.60,
and where the degrees of substitution of phosphate
ions by carbonate and silicate ions in all cases were
constant and х = y = 1. Thus, in terms of chemical
composition, all samples were calcium-deficient. The
samples were denoted as BMHAP1.50, BMHAP1.55,
and BMHAP1.60, respectively. The reference to com-
pare with was unmodified stoichiometric HAP with
Ca/P = 1.67 (mol/mol) synthesized in the absence of
silicate and carbonate ions, but in the presence of
citrate ions according to the equation
Physicochemical and biological studies of the syn-
thesized samples were carried out using a set of meth-
ods. The phase composition was studied on a Rigaku-
SmartLab diffractometer. The accelerating voltage
was 40 kV, the X-ray tube current was 250 mA, 2θ =
20°–70° with 0.02° steps, and recording rate was
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identified in the PDXL Qualitative Analysis program
using the PDF 2008 database. The crystallite size D
and crystallinity Xs in the samples were determined by
a routine procedure [28, 29]. IR absorption spectra
were recorded on an IRPrestige-21 (Shimadzu) FTIR
spectrometer in the wavenumber range from 400 to
4000 cm–1. The morphology and particle sizes in the
form of aqueous dispersions and in the form of dried
BMHAP powders were determined by digitizing
micrographs obtained using transmission (TEM) and
scanning (SEM) electron microscopy on JEM-2100
(JEOL) and Quanta-200 3D (FEI), respectively. The
images were digitized using the ImageJ software. Spe-
cific surface areas Ssp were determined by the BET
method on TriStar II 3020 (Micromeritics), a fully
automated surface area and porosity analyzer. The
surface charge magnitude and sign of the synthesized
samples were evaluated by measuring the electroki-
netic potential. ζ-Potentials were measured on a Zeta-
sizer Nano ZS (Malvern Instruments) serial analyzer.
The bioresorbability of the synthesized BMHAP sam-
ples in physiological saline (ω(NaCl) = 0.9%) and in
model SBF solution (рН 7.4) were evaluated as the
overall Ca2+ concentration in the solution by complex-
ometric titration after a certain exposure time [30].
RESULTS AND DISCUSSION
The X-ray powder diffraction phase study of the
synthesized samples showed that all BMHAP samples
having the molar ratios in the range 1.50–1.60 are sin-
gle phases and are nanocrystalline (Fig. 1a), and can
be attributed to the hexagonal crystal system (they
P63/m) and identified as modified HAP (ICDD No.
01-072-1243).
Noteworthy, the diffraction patterns of BMHAP
powders are distinguished by wider lines and lower
intensities compared to unmodified stoichiometric
HAP1.67 (Fig. 1b). The observed reduction in inten-
sity of the characteristic peaks in the synthesized
BMHAP samples is apparently associated with the
incorporation of silicate and carbonate ions into the
HAP crystallochemical structure. Thus, the measured
X-ray diffraction patterns are identical to those of a
typical HAP.
Crystallochemical and textural characteristics of
powdered HAP and BMHAP appear in Table 1.
As one can see from Table 1, an increase in molar
ratio in the HAP crystal structure in the range 1.50–
1.67 causes a monotonic increase in parameter с. For
parameter а, this trend was not observed. The highest
value of parameter а (0.9523 nm) is in BMHAP1.55.
As the molar ratio increases further, parameter a
begins to decrease to reach a minimum (0.9422 nm) in
HAP1.67. The unit cell volume changes in the same
way as parameters а and с. However, we did not eluci-
dated any definite trends in the unit cell parameters ofl. 66  No. 5  2021
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Fig. 1. X-ray diffraction patterns of synthesized samples: (a) general view and (b) diffraction peak (211) and its fit by three Lorent-
zian functions.












































2θ, degBMHAP depending on the molar ratio. Apparently,
this issue requires separate research.
With a decrease in Ca2+ deficiency in the molar
ratio range 1.50–1.60, the crystallite size increases
from 7.52 to 11.52 nm. As the molar ratio approaches
the stoichiometric value, the crystallite size changes in
jump to reach a peak (70.30 nm) in HAP1.67.
The results of BET specific surface area measure-
ments of the synthesized powders showed that all the
studied BMHAP samples have highly developed sur-
faces compared to unmodified stoichiometric
HAP1.67. The peak value of specific surface area
(193.53 m2/g) was in BMHAP1.55. The specific sur-
face areas of the synthesized samples were found to
decrease in response to the molar ratio increasing to
the stoichiometric value, to reach a minimum
(74.41 m2/g) in HAP1.67.
The FTIR spectra of all BMHAP powders doped
with silicate and carbonate ions in the range of speci-
fied molar ratios feature absorption bands of 3–4PO ,RUSSIAN JOURNAL O
Table 1. Unit cell parameters, crystallite sizes, and specific su
Vhex is unit cell volume; D is crystallite size; Xs is crystallinity; Ssp is





Ca10(PO4)6(OH)2 (01-072-1243) 0.943(2) 0.688(1), and OH– groups, characteristic of the apatite
phase.
The FTIR spectra (Fig. 2) of all HAP1.67 and
BMHAP samples feature absorption bands at wave-
numbers in the range 607–565 cm–1, corresponding to
the bending vibrations of phosphate groups (mode ν4).
Bands in the range 1092–1034 cm–1 can be assigned to
the asymmetric stretching vibrations of Р–О bonds in
the  tetrahedra (mode ν3), and bands in the range
962–959 cm–1 are caused by the symmetric stretching
modes ν1. The absorption band at 470 cm–1 corre-
sponds to the О–Р–О bending vibrations (mode ν2).
The broad band in the range from 3700 to 2500 cm–1
can be assigned to the stretching vibration modes of
adsorbate water and hydroxide groups. In addition,
bands of О–Н bending vibrations in structurally
bound water molecules and in hydroxide ions appear
in the range 1603–1635 cm–1. Presumably, the shift of
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rface areas of HAP1.67 and BMHAP samples
 specific surface area.
Vhex, nm3 D, nm Xs, % Ssp, m2/g
0.527(6) 7.52(0) 88.18 192.51
0.538(0) 8.22(7) 90.28 193.53
0.535(9) 11.52(3) 89.15 184.45
0.528(6) 70.30(5) 93.93 74.41
0.530(1) – –
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Fig. 2. IR spectra of synthesized HAP1.67 and BMHAP
samples.








































well as a significant increase in its intensity, can be
associated with an increase in the carbonate ion con-
centration in the HAP structure. The 630 cm–1 band
in the HAP spectrum can be assigned to the libration
vibrations of OH groups. Figure 2 shows that the
incorporation of both silicate and carbonate ions into
the HAP structure leads to the disappearance of this
band. After [31, 32], one OH group can be lost for pro-
viding charge compensation in the HAP unit cell when
 is substituted by . When HAP is doped
with  ions, one OH group can be lost due to
B-type carbonate substitution.
Unmodified stoichiometric HAP1.67 features
peaks corresponding to the peak vibrational intensity
of  groups at 1092 and 602 cm–1, but there are no
absorption bands characteristic of silicate groups. In
BMHAP samples, the phosphate group vibrations are
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Fig. 3. TEM micrographs of (a) HA
200 nm
(a)phosphate ions by silicate and carbonate ions. The
spectra of all samples also feature bands in the ranges
873–871 cm–1 (mode ν2) and 1456–1417 cm–1 (mode ν3),
respectively, related to the bending and stretching
С=О vibrations in the carbonate ion. In unmodified
stoichiometric HAP1.67, this may be due to the adsorp-
tion of carbon dioxide from the air during the synthesis.
The BMHAP samples feature broadening and an
increase in intensity of the band peaking at 1417 cm–1,
which corresponds to  vibrations (mode ν3). In our
opinion, this is due to the superposition of the 1417 cm–1
absorption band and the 1458 cm–1 band, which
occurs due to the incorporation of carbonate ions into
the HAP structure. In contrast to the FTIR spectrum
of stoichiometric HAP1.67, the spectra of silicate- and
carbonate-doped BMHAP powders exhibit character-
istic low-intensity absorption bands due to the bend-
ing vibrations of Si–O bonds and the symmetric
stretching vibrations of Si–O–Si bridging bonds in sil-
icate tetrahedra at 504 cm–1 (mode ν2) and ~720 cm–1
(mode ν1), respectively. The appearance of these
bands [31, 33] signifies that silicate ions have been
incorporated into the HAP lattice.
Morphological study of as-synthesized HAP1.67
and BMHAP samples in the form of aqueous disper-
sions was carried out by TEM. Figure 3 shows the
TEM images of samples HAP1.67 and BMHAP1.50.
As probed by TEM (Fig. 3), silicate and carbonate
ions doped into the HAP structure change the shape
and average particle size. Unmodified HAP1.67 has
acicular particles 45–100 nm long and 12–25 nm wide
(Fig. 3a). BMHAP1.50 samples are distinguished by
spherical particles with sizes in the range from 13 to 32 nm
(Fig. 3b). Laquerriere et al. [34] wrote that the spher-
ical shape of HAP particles is an important factor in
initiating the pro-inflammatory response, and the
needle-like shape of the HAP crystals is the least bio-
compatible one. Lebre et al. [35] reported that the
2–
3COl. 66  No. 5  2021
P1.67 and (b) BMHAP1.50 samples.
200 nm
(b)
658 TRUBITSYN et al.
Fig. 4. SEM micrographs of (a) HAP1.67, (b) BMHAP1.50, and (c) BMHAP1.60 samples.
20 μm 20 μm 20 μm
(a) (b) (c)
























acicular shape of HAP crystals with micrometer-sized
particles (0.1 to 20 μm) initiates the activation of infla-
masome NLRP3 and pronounced IL-1β secretion by
macrophages and dendritic bone marrow cells in mice
in vitro. At the same time, the inflammatory response
did not develop after the intraperitoneal injection of
micro- or submicron-sized HAP when the injected
HAP particles had a comparable size, but a smooth
spherical shape.
An additional structural and morphological study
of powdery HAP and BMHAP was carried out by
scanning electron microscopy after aqueous disper-
sions were dried. After the hydrogel was dried to con-
stant weight and then ground in a porcelain mortar,
the final synthesis products were fine white powders.
Figure 4 shows the SEM micrographs of as-dried
materials.
An inspection of the SEM images of HAP and
BMHAP samples confirmed that these powdered sub-
stances are polydisperse crystalline systems that have a
similar morphology and consist of nanoparticle
agglomerates with sizes of 2 to 23.5 μm for unmodified
HAP1.67 and of 1 to 10 μm for BMHAPSEM. The
micrographs in Fig. 4 show agglomerated microparti-
cles of the dried and pulverized product and not nano-
sized BMHAP particles dispersed in a liquid as in Fig. 3.
HAP crystals lose their hydrate shells while dried, and
are aggregated.
In addition to biocompatibility, bioactivity, and
osteoinduction, the electrical surface properties of the
synthesis products are extremely important for cal-
cium phosphate materials that are used as substrates
for the manufacture of bone implants, including
BMHAP. It is known that, when a biomaterial is
placed inside the body, a biological response immedi-
ately occurs at a depth of several nanometers from the
surface. At the same time, the surface charge at the
interface between the biomaterial and the biological
environment has a significant effect on protein
adsorption and cell adhesion. Preferential adsorption
of calcium cations occurs on negatively charged cal-
cium phosphate materials to form an apatite layer,RUSSIAN JOURNAL Owhich enhances the anchorage of proteins and cells to
the surface. From this point of view, HAP particles
bearing a controlled negative surface charge have a
noticeable advantage. The ζ-potentials of the synthe-
sized HAP and BMHAP samples are shown in Fig. 5.
According to the results of dynamic light scattering
measurements of ζ-potentials (Fig. 5), the particles of
all samples have negative charges in aqueous suspen-
sion at pH 7. The ζ-potential experiences a systematic
decrease in magnitude (from 4.29 to 1.05 mV) as the
molar ratio in the HAP structure increases in the range
1.50–1.67. So, BMHAP1.50, which has the greatest
Ca2+ deficiency, has the greatest negative value of the
ζ-potential (4.29 mV); as the molar ratio approaches
the stoichiometric value, the ζ-potential decreases to
reach a minimum in HAP1.67. Thus, for the synthe-
sized BMHAP samples, there is a wide range of varia-
tion in magnitude of the negative surface charge,
which makes it possible to control their adhesion
properties with respect to cells and proteins.F INORGANIC CHEMISTRY  Vol. 66  No. 5  2021
EFFECT OF MOLAR RATIOS 659
Table 2. Solubility of HAP1.67 and BMHAP powders in physiological saline (ω(NaCl) = 0.9%)
*Average of three determinations.
Temperature, °С
Ca2+ concentration, mmol/L*
BMHAP1.50 BMHAP1.55 BMHAP1.60 HAP1.67
22 4.10 3.75 3.60 1.10
37 4.60 4.00 3.90 2.05One more important characteristic of medical cal-
cium phosphate materials is resorbability. After Hendi
[8], in accordance with the division of the resorption
process into two (slow and fast) phases, which differ
from each other in pH in the resorption zone and the
involvement of cells in the process, the study of the
solubility of a biomaterial in water or model media can
serve as the basis to assess the bioresorbability of the
material. In hydroxyapatite biomaterials, bioresorb-
ability depends on several factors, such as the phase
composition, crystal size, specific surface area,
including the molar ratio in the HAP structure. In this
work, the bioresorbability of the synthesized samples
was assessed by their bioresorptive capacity, i.e., the
intensity of dissolution in physiological saline
(ω(NaCl) = 0.9%), which is isotonic to human blood
plasma, and in SBF solution, which simulates the
interstitial body f luid.
The results of solubility determination in HAP1.67
and BMHAP samples in the range 1.50–1.67 (mol/mol)
in physiological saline at room temperature (22°С)
and at the human body temperature (37°С) with 7-day
exposure appear in Table 2.
From the data in Table 2, one can see that BMHAP
samples have improved bioresorption compared to
unmodified stoichiometric HAP1.67. This behavior is
in good agreement with Safronova and Putlyaev’s dataRUSSIAN JOURNAL OF INORGANIC CHEMISTRY  Vo




































[10], according to which the solubility increases when
substituent anions have a lower charge and/or a larger
radius with a higher hydration energy. For the studied
BMHAP samples, the substitution of phosphate ions
by silicate and carbonate ions leads to a distortion of
the crystal lattice and creates stresses and instability in
the HAP structure, which is just responsible for an
increased solubility of the material. The solubility in
BMHAP samples tends to decrease as the molar ratio
increases. So, BMHAP1.50 has a maximum concen-
tration (4.10 mmol/L) of Ca2+ ions that pass into the
liquid phase when the solid is brought into contact
with physiological saline. The minimum Ca2+ con-
centration (1.10 mmol/L) at the set exposure time was
observed for stoichiometric HAP1.67. Thus, after the
samples were exposed for 7 days in 0.9% NaCl saline,
the Ca2+ concentration in BMHAP samples was 1.9–
2.4 times higher than that in unmodified stoichiomet-
ric HAP1.67. In addition, an increase in solubility in
response to the temperature increasing from 22 to
37°C is also noted for all synthesized HAP and
BMHAP samples (Table 2).
In order to assess the in vitro biological activity of
the synthesized HAP and BMHAP samples, the sam-
ples were kept in a model SBF solution (pH 7.4) at a
constant temperature of 37 ± 0.5°C for 14 days. At the
end of the exposure of the samples in the saturated
SBF solution, their bioresorbability was assessed as
the quantitative release of Са2+. The results are shown
in Fig. 6.
Figure 6 implies that the dissolution curves in SBF
solution have similar trends for all studied samples.
The release of Ca2+ ions from HAP1.67 and BMHAP
into the SBF solution increases rapidly during the first
day to reach the maximum equilibrium value C(Ca2+)
in 5–7 days. After this period of time, the amount of
Ca2+ ions released into the liquid phase decreases
slightly, and then remains at a constant level. This fact,
apparently, is associated with the formation of a poorly
soluble apatite layer on the BMHAP surface, which
complicates its further dissolution; as a consequence,
there is a slight decrease in Ca2+ concentration in the
solution. It is known that Ca2+,  , and OH–
ions released from calcium phosphate materials like
BMHAP play an important role in the formation of a
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compared to unmodified HAP1.67. From the analysis
of the kinetic curves, it follows that BMHAP biore-
sorbability systematically decreases as the molar ratio
increases in the range 1.50–1.67. The highest release
of Ca2+ ions into the SBF solution is observed for the
BMHAP1.50 sample, and the least is for the stoichio-
metric sample HAP1.67.
CONCLUSIONS
Nanostructured biomimetic hydroxyapatite sam-
ples have been synthesized by chemical precipitation
from aqueous solutions. While the molar ratio
increases in the range 1.50–1.67, unit cell parameters
а and с change, the average crystallite size increases
from 7.52 to 70.30 nm, and the specific surface area
decreases. In aqueous suspensions (pH 7), suspension
particles and particles of all samples bear negative
charges. The trend has been elucidated in which the
ζ-potential of the powder changes in the studied range
of molar ratios.
Bioactivity studies by dynamic dissolution in 0.9%
NaCl saline and in the SBF solution have shown that
the resorption rates of HAP1.67 and BMHAP
decrease as the molar ratio increases in the crystal-
lochemical structure of the sample.
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